Filter
799
Text search:
drug
prices
Featured
Recommendations
71
New Publications
248
Language
Document type
No document type
486
Studies & Reports
163
Guidelines
74
Strategic & Response Plan
33
Manuals
18
Fact sheets
8
Situation Updates
7
Training Material
4
Resource Platforms
3
Infographics
3
Countries / Regions
India
30
Kenya
28
Global
28
Uganda
21
Myanmar / Burma
20
Western and Central Europe
17
Liberia
15
Nepal
15
Malawi
15
Zambia
14
South Africa
14
Ukraine
12
Sierra Leone
11
Nigeria
11
Ghana
11
Tanzania
11
Bangladesh
11
Zimbabwe
9
Latin America and the Carribbean
9
Africa
9
Ethiopia
8
Philippines
8
Syria
8
Indonesia
8
Congo, Democratic Republic of
7
Namibia
7
Botswana
7
South–East Asia Region
7
Cameroon
6
Mozambique
6
Asia
6
Eastern Europe
6
Rwanda
5
Senegal
4
Haiti
4
Cambodia
4
Burkina Faso
3
Eswatini/ Swaziland
3
Lesotho
3
Venezuela
3
Tajikistan
3
Guinea
2
Pakistan
2
Jordan
2
North Macedonia
2
Middle East and North Africa
2
Paraguay
2
Albania
2
Russia
2
Moldova
2
Kyrgyzstan
2
Georgia
2
USA
1
South Sudan
1
Afghanistan
1
Germany
1
Lebanon
1
Thailand
1
China
1
Sudan
1
Benin
1
Central African Republic
1
Serbia
1
Colombia
1
Bolivia
1
Libya
1
Sri Lanka
1
Eastern Europe and Central Asia
1
Bhutan
1
North Korea
1
Armenia
1
Mongolia
1
Southern Africa
1
Laos
1
Timor Leste/ East Timor
1
Bulgaria
1
Estonia
1
Uzbekistan
1
Kazakhstan
1
Vietnam
1
Gabon
1
Turkmenistan
1
Authors & Publishers
Publication Years
Category
Countries
312
Clinical Guidelines
82
Public Health
47
Pharmacy & Technologies
19
Key Resources
18
Women & Child Health
17
Capacity Building
3
Toolboxes
HIV
105
Mental Health
78
Pharmacy
56
TB
46
AMR
45
COVID-19
31
Global Health Education
18
NCDs
17
Health Financing Toolbox
13
Conflict
12
NTDs
10
Planetary Health
9
Ebola
8
Refugee
8
Disability
7
Rapid Response
6
Caregiver
6
Polio
4
Natural Hazards
3
Cholera
2
May 2018
HIV i-Base
ISSN 1475-2077 www.i-Base.info
Watch for out-of-date information
First questions
You and your doctor Resistance and adherence Treatment choices
Front. Public Health, 30 April 2021 | https://doi.org/10.3389/fpubh.2021.628744
Time has seen management for Cystic Fibrosis (CF) advance drastically, most recently in the development of the disease-modifying triple combination therapy ivacaftor/tezacaftor/elexacaftor. There is currently limited evidence regarding both the global epidemiology of CF and access to this transforma
...
Recommendations for a public health approach
2010 revision
Millennium Development Goal 8E aims for affordable access to essential medicines. Essential medicines, as defined by WHO, are those that “satisfy the health-care needs of the majority of the population” and that should therefore “be available at all times in adequate amounts”. However, there
...
The occurrence of a high percentage of couterfeit medicines on the global medicines market is often attributed to a lack of effective regulation and a weak enforcement capacity. This review, while focusing on counterfeit medicines and medical devices in developing countries, will present information
...
Global UNIDO Project: Strengthening the local production of essential generic drugs in the least developed and developing countries
Towards the Peoples Health Assembly Book - 4
The handbook on supply chain management for HIV/AIDS commodities was written to assist program managers to plan and implement day–to-day management of all drugs and medical supplies for an HIV/AIDS program. Many of the suggested techniques described in this handbook are helpfu
...
